IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Polyp Detection With The Peerscope System™
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The PeerScope System consists of Peer Medical camera heads, endoscopes, video system, light source and other ancillary equipment. The system is intended for endoscopic diagnosis, treatment and video observation of the digestive tract. The PeerScope system model B is indicated for use for endoscopy and endoscopic treatment within the lower digestive tract (including the anus, rectum, sigmoid colon, colon and ileocecal valve) of adults patients.
Objective:To compare the additional diagnostic yield obtained by using the PeerScope System™ extended view vs. the diagnostic yield obtained by the Standard view colonoscopy.
In addition, time measurements including time to cecum, time for withdrawal and overall procedure time will be analyzed and reported for each group.
| Condition | Intervention | Phase |
|---|---|---|
| Colon Polyps and Adenomas Colon Cancer | Device: Colonoscopy done with:PeerMedical System and Olympus/Pentax/Fuji colonoscopy system | Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind (Participant) Primary Purpose: Screening |
| Official Title: | Polyp Detection With The Peerscope System™: A Randomized Tandem Colonoscopy Study |
- polyp detection rate [ Time Frame: 1 year ]
Sample size calculation is based on detecting a difference in the adenoma overall detection rate and the overall polyp detection rate using the PeerScope System™ extended view as compared to Standard view colonoscopy.
Total sample size will be 196 patients. Each patient will undergo the procedure by the two devices: PeerScope System™ extended view and Standard view colonoscopy. The rational for this sample size is based on detecting a rate difference of 20% between the study devices.
| Enrollment: | 197 |
| Study Start Date: | February 2012 |
| Study Completion Date: | July 2013 |
| Primary Completion Date: | March 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Group A (study group)
Subjects in Group A (study group) will undergo a Standard view colonoscopy followed immediately by a PeerScope System™ extended view colonoscopy.
|
Device: Colonoscopy done with:PeerMedical System and Olympus/Pentax/Fuji colonoscopy system
endoscopic diagnosis, treatment and video observation of the digestive tract, endoscopy and endoscopic treatment within the lower digestive tract (including the anus, rectum, sigmoid colon, colon and ileocecal valve) of adults patients
Other Names:
|
|
Active Comparator: Group B (control group)
Group B (control group) will undergo a PeerScope System™ extended view colonoscopy followed immediately by a Standard view colonoscopy.
|
Device: Colonoscopy done with:PeerMedical System and Olympus/Pentax/Fuji colonoscopy system
endoscopic diagnosis, treatment and video observation of the digestive tract, endoscopy and endoscopic treatment within the lower digestive tract (including the anus, rectum, sigmoid colon, colon and ileocecal valve) of adults patients
Other Names:
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Subject between the ages of 18 and 70
- The patient is undergoing colonoscopy for screening, for surveillance in follow-up of previous polypectomy or for diagnostic workup;
- Written informed consent must be available before enrollment in the trial
- For women with childbearing potential, adequate contraception
Exclusion Criteria:
- Patients with a history of colonic resection;
- Patients with known (or newly diagnosed) inflammatory bowel disease;
- Patients with a personal history of polyposis syndrome;
- Patients with suspected chronic stricture potentially precluding complete colonoscopy;
- Patients with diverticulitis or toxic megacolon;
- Patients with a history of radiation therapy to abdomen or pelvis;
- Patients with acute lower GI bleeding
- Patients who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the patient's participation in this study.
Contacts and LocationsPlease refer to this study by its ClinicalTrials.gov identifier: NCT01549535
| United States, New York | |
| North Shore Gasstroenterology Assoiates, P.C. | |
| NY, New York, United States | |
| Southshore Gasstroenterology, P.C | |
| NY, New York, United States | |
| Israel | |
| Carmel Medical Center | |
| Haifa, Israel | |
| Elisha Medical Center | |
| Haifa, Israel | |
| The Tel Aviv Sourasky Medical Center | |
| Tel Aviv, Israel | |
| Netherlands | |
| UMC | |
| Utrecht, Netherlands | |
| Principal Investigator: | Ian Gralnek, Prof. | Rambam Health Care Campus |
| Principal Investigator: | Peter Siersema, Prof. | UMC Utrecht |
| Principal Investigator: | Erwin Santo, Prof. | The Tel Aviv Sourasky Medical Center |
| Principal Investigator: | Ori Segol, Dr. | Carmel Medical Center |
| Principal Investigator: | Alan Sloyer, Dr. | North Shore Gastroenterology Associates, P.C. |
| Principal Investigator: | Jay S. Fenster, Dr. | Southshore Gasstroenterology, P.C |
More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | PeerMedical Ltd. |
| ClinicalTrials.gov Identifier: | NCT01549535 History of Changes |
| Other Study ID Numbers: |
CD-1158 |
| Study First Received: | February 13, 2012 |
| Last Updated: | November 22, 2016 |
Additional relevant MeSH terms:
|
Polyps Adenoma Pathological Conditions, Anatomical |
Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms |
ClinicalTrials.gov processed this record on June 28, 2017